FindTrial
Sign In

Ningmitai capsule

DRUG5 trials

Sponsors

Xintian Pharmaceutical

Conditions

Benign Prostatic Hyperplasia With Lower Urinary Tract SymptomsChronic ProstatitisChronic Prostatitis With Chronic Pelvic Pain SyndromeErectile DysfunctionUreteral Calculi

Phase 4

The Efficacy and Safety of Silodosin Singly or Combined With Ningmitai Capsules in the Treatment of Benign Prostatic Hyperplasia
RecruitingNCT05551221
Xintian PharmaceuticalBenign Prostatic Hyperplasia With Lower Urinary Tract Symptoms
Start: 2022-07-18End: 2026-12-31Target: 312Updated: 2022-09-23
Efficacy and Safety of Ningmitai Capsule in Patients With Chronic Prostatitis/Chronic Pelvic Pain Syndrome
CompletedNCT05890235
Xintian PharmaceuticalChronic Prostatitis
Start: 2018-11-16End: 2022-07-10Updated: 2023-06-06
Clinical Observation of Ningmitai Capsule in Treating Chronic Pelvic Pain Syndrome With Erectile Dysfunction
CompletedNCT06064448
Xintian PharmaceuticalChronic Prostatitis With Chronic Pelvic Pain Syndrome, Erectile Dysfunction
Start: 2019-03-19End: 2022-12-22Updated: 2023-10-12
Clinical Study of Ningmitai Capsule on Promoting the Passage of Residual Fragments After Ureteroscopic Lithotripsy
CompletedNCT06105827
Xintian PharmaceuticalUreteral Calculi
Start: 2016-10-02End: 2019-04-25Updated: 2023-10-30
Efficacy and Safety of Ningmitai Capsule Alone or Combined With Celecoxib in the Treatment of CP/CPPS
CompletedNCT06159114
Xintian PharmaceuticalChronic Prostatitis
Start: 2023-12-19End: 2025-01-31Updated: 2025-08-06

Related Papers

Ningmitai capsule in patients with chronic prostatitis/chronic pelvic pain syndrome: a multicenter, prospective, randomized, parallel, positive-controlled study.
2025-12-03
The efficacy of combination therapy with Ningmitai capsule and sildenafil in men with chronic prostatitis/chronic pelvic pain syndrome and erectile dysfunction: a prospective, multicenter, randomized controlled trial
Sexual Medicine2025-04-011 citations